DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
drugs per page:
Showing 1 to 1 of 1 drugs
Filter by
Reset
|
No.
KEGG DRUG
DrugBank
Drug (Description in trials)
KEGG GENES
KEGG PATHWAY
Disease ID
1
Ravulizumab
1.
Ravulizumab
×
Name
Other Names
Ravulizumab
Ravulizumab (USAN)
Ravulizumab (genetical recombination) (JAN)
Ultomiris (TN)
💬
[1]
Ravulizumab
Ravulizumab
[2]
RAVULIZUMAB
RAVULIZUMAB
;
Ultomiris
[1]
C5
C5
💬
1.
Ravulizumab
×
Name
Full Name
C5
complement C5
[11]
Alcoholic liver disease
Alcoholic liver disease
,
Complement and coagulation cascades
,
Coronavirus disease - COVID-19
,
Herpes simplex virus 1 infection
,
Neuroactive ligand-receptor interaction
,
Neutrophil extracellular trap formation
,
Pertussis
,
Prion disease
,
Regulation of actin cytoskeleton
,
Staphylococcus aureus infection
,
Systemic lupus erythematosus
💬
[11]
Alcoholic liver disease
,
Complement and coagulation cascades
,
Coronavirus disease - COVID-19
,
H
...
[7]
2
2
,
11
,
13
,
50
,
62
,
66
,
109
💬
1.
Ravulizumab
×
Disease ID
Name
2
Amyotrophic lateral sclerosis
11
Myasthenia gravis
13
Multiple sclerosis/Neuromyelitis optica
50
Dermatomyositis
62
Paroxysmal nocturnal hemoglobinuria
66
IgA nephropathy
109
Atypical hemolytic uremic syndrome